SLC30A8 and type 1 diabetes mellitus: Fifty years ago, ZnT8 was recognized as an autoantigen in T1D, and ZnT8-Ab introduction into the routine diagnostic process of T1D may improve the overall autoantibody sensitivity in different countries [5, 23].